Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)
- DOI
- 10.7759/cureus.113371
- Published
- 2026-07-25
- Container
- Cureus
- Publisher
- Springer Science and Business Media LLC
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.7759/cureus.113371,
title = {Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026)},
author = {Abhinandan Singla and Gurnoor Kaur and Gurpreet Singh and Shivansh Luthra and Chirag Lodha and Omar Alneser and Mohammed S Alo and Syed S Ali and Muhammad Zulqarnain},
year = {2026},
journal = {Cureus},
doi = {10.7759/cureus.113371},
url = {https://doi.org/10.7759/cureus.113371}
}RIS
TY - JOUR TI - Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026) AU - Abhinandan Singla AU - Gurnoor Kaur AU - Gurpreet Singh AU - Shivansh Luthra AU - Chirag Lodha AU - Omar Alneser AU - Mohammed S Alo AU - Syed S Ali AU - Muhammad Zulqarnain PY - 2026 JO - Cureus DO - 10.7759/cureus.113371 UR - https://doi.org/10.7759/cureus.113371 ER -
APA
Singla, A., Kaur, G., Singh, G., Luthra, S., Lodha, C., Alneser, O., Alo, M. S., Ali, S. S., & Zulqarnain, M. (2026). Comparative Cardiovascular Pharmacovigilance of Semaglutide and Tirzepatide: A Food and Drug Administration Adverse Event Reporting System (FAERS) Database Analysis (2022-2026). Cureus. https://doi.org/10.7759/cureus.113371
Source records
- crossref · retrieved 2026-09-26T01:13:53.232Z